Nuclear Medicine and Biology
Volume 35, Issue 4 , Pages 475-479, May 2008

Metabolism and autoradiographic evaluation of [18F]FE@CIT: a Comparison with [123I]β-CIT and [123I]FP-CIT

  • Dagmar E. Ettlinger

      Affiliations

    • Department of Nuclear Medicine, Medical University of Vienna, A-1090 Vienna, Austria
  • ,
  • Daniela Häusler

      Affiliations

    • Department of Nuclear Medicine, Medical University of Vienna, A-1090 Vienna, Austria
    • Department of Nuclear Medicine, Medical University of Vienna, A-1090 Vienna, Austria
  • ,
  • Wolfgang Wadsak

      Affiliations

    • Department of Nuclear Medicine, Medical University of Vienna, A-1090 Vienna, Austria
    • Department of Nuclear Medicine, Medical University of Vienna, A-1090 Vienna, Austria
  • ,
  • Friedrich Girschele

      Affiliations

    • Department of Nuclear Medicine, Medical University of Vienna, A-1090 Vienna, Austria
  • ,
  • Karoline M. Sindelar

      Affiliations

    • Department of Nuclear Medicine, Medical University of Vienna, A-1090 Vienna, Austria
  • ,
  • Leonhard-Key Mien

      Affiliations

    • Department of Nuclear Medicine, Medical University of Vienna, A-1090 Vienna, Austria
    • Department of Nuclear Medicine, Medical University of Vienna, A-1090 Vienna, Austria
    • Department of Nuclear Medicine, Medical University of Vienna, A-1090 Vienna, Austria
  • ,
  • Johanna Ungersböck

      Affiliations

    • Department of Nuclear Medicine, Medical University of Vienna, A-1090 Vienna, Austria
    • Department of Nuclear Medicine, Medical University of Vienna, A-1090 Vienna, Austria
  • ,
  • Helmut Viernstein

      Affiliations

    • Department of Nuclear Medicine, Medical University of Vienna, A-1090 Vienna, Austria
  • ,
  • Kurt Kletter

      Affiliations

    • Department of Nuclear Medicine, Medical University of Vienna, A-1090 Vienna, Austria
  • ,
  • Robert Dudczak

      Affiliations

    • Department of Nuclear Medicine, Medical University of Vienna, A-1090 Vienna, Austria
  • ,
  • Markus Mitterhauser

      Affiliations

    • Corresponding Author InformationCorresponding author. Department of Nuclear Medicine, AKH Wien, Waehringer Guertel 18-20, A-1090 Vienna, Austria. Tel.: +43 1 40400 1557; fax: +43 1 40400 1559.
    • Department of Nuclear Medicine, Medical University of Vienna, A-1090 Vienna, Austria
    • Department of Nuclear Medicine, Medical University of Vienna, A-1090 Vienna, Austria
    • Department of Nuclear Medicine, Medical University of Vienna, A-1090 Vienna, Austria

Received 12 December 2007; received in revised form 18 February 2008; accepted 28 February 2008.

Abstract 

Purpose

Since the late 1980s, cocaine analogues based on the phenyltropane structure, such as [11C]CFT and [123I]β-CIT have been used for the imaging of the dopamine transporter. FE@CIT (fluoropropyl ester) and FP-CIT (N-fluoropropyl derivative) are further analogues. The aim of this study was to (1) evaluate and compare the metabolic stability of β-CIT, FP-CIT and FE@CIT against carboxyl esterases and (2) evaluate selectivity of [18F]FE@CIT compared to [123I]β-CIT and [123I]FP-CIT using autoradiography.

Methods

In vitro enzymatic hydrolysis assays were performed using different concentrations of β-CIT, FE@CIT and FP-CIT with constant concentrations of carboxyl esterase. Autoradiography was performed on coronal 20-μm rat brain sections incubated with different radioactivity concentrations of [123I]β-CIT, [123I]FP-CIT or [18F]FE@CIT and, additionally, with 3-amino-4-(2-dimethylaminomethyl-phenylsulfanyl)-benzonitrile [serotonin transporter (SERT)] and nisoxetine [norepinephrine transporter (NET)] for blocking experiments.

Results

In vitro assays showed Michaelis-Menten constants of 175 μmol (β-CIT), 183 μmol (FE@CIT) and 521 μmol (FP-CIT). Limiting velocities were 0.1005 μmol/min (β-CIT), 0.1418 μmol/min (FE@CIT) and 0.1308 μmol/min (FP-CIT). This indicates a significantly increased stability of FP-CIT, whereas carboxyl esterase stability of β-CIT and FE@CIT showed no significant difference. Autoradiographic analyses revealed a good correlation between dopamine transporter (DAT)-rich regions and the uptake pattern of FE@CIT. Blocking experiments showed a higher DAT selectivity for [18F]FE@CIT than for the other two tracers.

Conclusion

We found that (1) the metabolic stability of FE@CIT was comparable to that of β-CIT, whereas FP-CIT showed higher resistance to enzymatic hydrolysis; and (2) the overall uptake pattern of [18F]FE@CIT on brain slices was comparable to that of [123I]β-CIT and [123I]FPCIT. After blocking of NET and SERT binding, a significantly higher DAT selectivity was observed for [18F]FE@CIT. Hence, [18F]FE@CIT may be of interest for further clinical application.

Keywords: FE@CIT, DAT, Metabolism, Autoradiography

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0969-8051(08)00064-4

doi:10.1016/j.nucmedbio.2008.02.008

Nuclear Medicine and Biology
Volume 35, Issue 4 , Pages 475-479, May 2008